Iron deficiency anemia in patients with heavy menstrual bleeding: The patients' perspective from diagnosis to treatment.

ABSTRACT:

Background

Heavy menstrual bleeding (HMB) associated with iron deficiency anemia (IDA) negatively affects quality of life (QoL). Management of IDA usually begins with oral iron supplementation or, if ineffective/poorly tolerated, then intravenous iron (IVI) is given; however, no guidance exists on transitioning from oral to IVI in patients with HMB. While various IVI products exist, safety profiles and distinct properties affecting treatment logistics make product choice important.

Objectives

Assess the IVI treatment journey for patients with HMB and IDA.

Design

A survey was designed to assess multiple aspects of IVI treatment to evaluate patient perspectives.

Methods

Patients (⩾18 years) from the United States with IDA currently prescribed IVI completed a surv

SUBMITTER: Akpan IJ 

PROVIDER: S-EPMC11869313 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature